Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

NCT02496585 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Lung Metastases

Interventions

DRUG: Nintedanib
DRUG: Prednisone
OTHER: Placebo

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]